A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy

Clinical trial NCT05621317 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05621317
Sponsor: Aravax Pty Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Peanut Allergy Peanut Hypersensitivity Peanut-Induced Anaphylaxis Immune System Diseases

Start date: 2023-02-09
Primary completion: 2025-11-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.